SK284884B6 - Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK284884B6
SK284884B6 SK860-2001A SK8602001A SK284884B6 SK 284884 B6 SK284884 B6 SK 284884B6 SK 8602001 A SK8602001 A SK 8602001A SK 284884 B6 SK284884 B6 SK 284884B6
Authority
SK
Slovakia
Prior art keywords
proanthocyanidin
phospholipid
complexes
proanthocyanidine
pharmaceutical composition
Prior art date
Application number
SK860-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK8602001A3 (en
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S. P. A. filed Critical Indena S. P. A.
Publication of SK8602001A3 publication Critical patent/SK8602001A3/sk
Publication of SK284884B6 publication Critical patent/SK284884B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK860-2001A 1998-12-18 1999-12-13 Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie SK284884B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
PCT/EP1999/009854 WO2000037062A2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents

Publications (2)

Publication Number Publication Date
SK8602001A3 SK8602001A3 (en) 2001-12-03
SK284884B6 true SK284884B6 (sk) 2006-02-02

Family

ID=11381268

Family Applications (1)

Application Number Title Priority Date Filing Date
SK860-2001A SK284884B6 (sk) 1998-12-18 1999-12-13 Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (22)

Country Link
US (1) US6429202B1 (cs)
EP (1) EP1140115B1 (cs)
JP (1) JP4842436B2 (cs)
KR (1) KR100694907B1 (cs)
CN (1) CN1146429C (cs)
AT (1) ATE238803T1 (cs)
AU (1) AU763907B2 (cs)
CA (1) CA2355776C (cs)
CZ (1) CZ301495B6 (cs)
DE (1) DE69907509T2 (cs)
DK (1) DK1140115T3 (cs)
ES (1) ES2197708T3 (cs)
HK (1) HK1042430B (cs)
HU (1) HU228928B1 (cs)
IL (2) IL143751A0 (cs)
IT (1) IT1304183B1 (cs)
NO (1) NO328733B1 (cs)
PL (1) PL197153B1 (cs)
PT (1) PT1140115E (cs)
RU (1) RU2248798C2 (cs)
SK (1) SK284884B6 (cs)
WO (1) WO2000037062A2 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
CA2475630C (en) * 2002-02-12 2011-01-18 Hunza Di Pistolesi Elvira & C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
AU2005209317B2 (en) * 2004-01-28 2011-07-07 Mars, Incorporated Compositions and methods of use of A-type procyanidins
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
JP5443015B2 (ja) * 2008-02-19 2014-03-19 株式会社岐阜セラツク製造所 医薬組成物
IT1398624B1 (it) * 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
RU2456674C1 (ru) * 2011-05-31 2012-07-20 Тагир Уралович Гафаров Способ моделирования атрофического рубца кожи
CN102688501A (zh) * 2012-06-20 2012-09-26 浙江萧山医院 原花青素b2磷脂复合物及其制备方法和用途
CN103120798A (zh) * 2013-01-10 2013-05-29 施冬云 一种具有抗氧化应激作用的磷脂复合物制备方法及其应用
CN103467778B (zh) * 2013-09-06 2015-09-30 天津大学 细菌纤维素/卵磷脂复合材料及制备和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5648377A (en) 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
FI955691A (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
WO2001019009A1 (de) 1999-09-08 2001-03-15 Siemens Aktiengesellschaft Anordnung und verfahren für eine optische informationsübertragung

Also Published As

Publication number Publication date
EP1140115B1 (en) 2003-05-02
RU2248798C2 (ru) 2005-03-27
AU763907B2 (en) 2003-08-07
ITMI982732A1 (it) 2000-06-18
ES2197708T3 (es) 2004-01-01
JP2002532543A (ja) 2002-10-02
SK8602001A3 (en) 2001-12-03
HU228928B1 (en) 2013-06-28
AU2283000A (en) 2000-07-12
JP4842436B2 (ja) 2011-12-21
EP1140115A2 (en) 2001-10-10
HUP0104665A3 (en) 2003-01-28
IT1304183B1 (it) 2001-03-08
HK1042430A1 (en) 2002-08-16
PL197153B1 (pl) 2008-03-31
NO20012944L (no) 2001-06-14
CZ20012134A3 (cs) 2001-12-12
IL143751A (en) 2006-07-05
ATE238803T1 (de) 2003-05-15
DE69907509T2 (de) 2004-04-08
DE69907509D1 (en) 2003-06-05
HUP0104665A2 (hu) 2002-04-29
NO20012944D0 (no) 2001-06-14
CA2355776C (en) 2008-03-18
NO328733B1 (no) 2010-05-03
CN1330548A (zh) 2002-01-09
DK1140115T3 (da) 2003-08-25
CN1146429C (zh) 2004-04-21
CZ301495B6 (cs) 2010-03-24
HK1042430B (zh) 2004-10-08
US6429202B1 (en) 2002-08-06
KR20010093826A (ko) 2001-10-29
WO2000037062A3 (en) 2000-08-03
KR100694907B1 (ko) 2007-03-14
PT1140115E (pt) 2003-08-29
IL143751A0 (en) 2002-04-21
CA2355776A1 (en) 2000-06-29
WO2000037062A2 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
RU2272620C2 (ru) Способы снижения пролиферации клеток на основе (3r,4r)△8 - тетрагидроканнабинол-11-оновых кислот (кислот из конопли)
JPH02304084A (ja) 抗ウイルス性薬剤
US8821937B2 (en) Methods of treating cardiovascular disorders associated with atherosclerosis
EP0422109A1 (en) REDUCTION IN CELL REPRODUCTION AND INCREASE IN KILLER CELL ACTIVITY.
SK284884B6 (sk) Fosfolipidové komplexy proantokyanidínu A2, farmaceutický prostriedok s ich obsahom a ich použitie
US20170258917A1 (en) Solubility of therapeutic agents
TW317500B (cs)
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
JP4456267B2 (ja) 抗アテローム性動脈硬化剤としてのヴィティス・ヴィニフェラ(vitisvinifera)抽出物のリン脂質複合体の使用
EP3559892A1 (en) Methods for treating mitochondrial disorders
CN111031813A (zh) 用于预防和治疗心血管器官病症的组合物
PL375295A1 (pl) Zastosowanie genisteiny do leczenia łuszczycy i środek farmaceutyczny do leczenia łuszczycy
WO2013081452A1 (en) Phosphatidylinositol
JPS58206521A (ja) 抗腫瘍剤
ITMI941036A1 (it) Impiego dell'epilattosio nel trattamento dei tumori e delle malattie autoimmuni
JPS58206525A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20161213